Recursion Pharmaceuticals (NASDAQ: RXRX) has been a pioneer in using artificial intelligence (AI) to improve the drug discovery process. The company, founded in 2013, has been working on that project ...
SALT LAKE CITY - Recursion (NASDAQ:RXRX) announced Monday that Vicki Goodman, M.D., will become Chief Medical Officer effective April 6, 2026, replacing David Mauro, M.D., Ph.D., who is transitioning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results